Mymetics Corp (MYMX)
Mymetics Corp is a common stock listing of Mymetics Corporation, a healthcare biotechnology company based in Epalinges, Switzerland. The company focuses on research and development of vaccines for infectious and life-disabling diseases. Its pipeline includes candidates targeting HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus, and malaria. Mymetics has also entered into collaboration agreements with Texas Biomedical Research Institute and the National Institutes of Health. Founded in 1990, the company was previously known as ICHOR Corporation and adopted the Mymetics name in July 2001.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MYMX
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 18, 2026
|
—
|
—
|
—
|
0.045 K
|
—
|
—
|
—
|
—
|
—
|
—
|
